Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients
Clinical trial NCT02346175 · COMPLETED
Trial details
- NCT number
- NCT02346175
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.